×

Disaster du Jour & Sunshine Stocks

2:22 PM ET Fri, 12 Oct 2012

Chipmaker Advanced Micro Devices is cutting fiscal Q3 revenue guidance, and NPS Pharmaceuticals is popping after the FDA issued an upbeat preview of its short bowel syndrome drug Gattex, with CNBC's Amanda Drury and Brian Sullivan.